Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

ESMO PracticeUpdate Conference Series:

Videos from #ESMO20 on CNS Malignancies

Key Takeaways from ESMO: Enhancing Prognostication for Glioblastoma

Roger Stupp

  1. What prognostic variables have historically been most important for patients with glioblastoma?
  2. Do we learn anything about these traditional prognostic bio-markers from the presentations at this conference?
Key Takeaways from ESMO: Managing Brain Metastases

Manmeet Ahluwalia

  1. Could you outline some of the key research in brain metastases presented at this year's ESMO?
  2. How was the study designed?
  3. As a neuro-oncologist, what stood out to you?
  4. How does this compare to other therapies in the NSCLC brain metastases setting?
  5. What other studies were particularly important in the context of managing brain metastases from lung cancer?
  6. What impact did osimertinib have on brain metastases?
  7. What other drugs showed promise in this setting?

The ESMO PU Conference Series – A collaboration brought to you by Elsevier’s PracticeUpdate and the European Society for Medical Oncology.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings